🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Biological therapies, such as CC-4047, may stimulate the immune ...
Status
Completed
Location
Mayo Clinic
Start Date
2008-05
Trial ID
NCT00669578
Treatments Being Tested
The purpose of the Phase 1 part of the study is to determine the maximum to...
Status
Terminated
Location
California Cancer Associates For Research and Exellence, cCare
Start Date
2014-07-30
Trial ID
NCT01999335
Treatments Being Tested
This is a Phase I/II study using the combination of twice weekly ixazomib p...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2019-09-18
Trial ID
NCT04094961
Treatments Being Tested
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795
This study is researching a drug called linvoseltamab (also called "study d...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2026-01-02
Trial ID
NCT07222761
Treatments Being Tested
The main purpose of this study is to see whether pomalidomide can help peop...
Status
Completed
Location
University of California San Francisco
Start Date
2011-11
Trial ID
NCT01432600
Treatments Being Tested
PMS period: 09Jun2017 \~ 08Jun2023 Target no.: 600patients indication: POM...
Status
Completed
Location
Korea University Ansan Hospital
Start Date
2017-12-28
Trial ID
NCT03288974
Treatments Being Tested
This randomized phase I/II trial studies the side effects and best dose of ...
Status
Unknown
Location
Anchorage Associates in Radiation Medicine
Start Date
2014-02
Trial ID
NCT02004275
Treatments Being Tested
1. Planned enrollment period One year (The planned number of patients to be...
Status
Completed
Location
Local Institution - Japan
Start Date
2015-04-30
Trial ID
NCT02921828
The main aim is to show that long-term use of ixazomib can improve symptoms...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05183139
Treatments Being Tested